Pulmicort Turbuhaler

Pulmicort Turbuhaler Warnings

budesonide

Manufacturer:

AstraZeneca

Distributor:

DKSH
Full Prescribing Info
Warnings
During transfer from oral steroid therapy to Pulmicort Turbuhaler, the patient may regain earlier symptoms eg, rhinitis, eczema and pain in muscles and joints. In these cases, a temporary increase in the dose of oral steroids is sometimes necessary. In general, insufficient steroid effect should be suspected if, in rare cases, symptoms eg, tiredness, headache, nausea and vomiting should occur.
Acute exacerbations of asthma may need complementary treatment with a short oral steroid regimen.
To minimize oropharyngeal thrush and systemic effects, the patient should rinse the mouth out with water after each dosing occasion.
Effects on the Ability to Drive or Operate Machinery: Pulmicort Turbuhaler does not affect the ability to drive or use machines.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in